The board meeting for Sutro Biopharma Inc is scheduled for today, for the purpose of Sutro Biopharma Inc First Quarter Earnings Results for 2026See details
Sutro Biopharma Inc has a share price target of US$ 36, revenue growth forecast of -70.6%, and profit growth estimate of 24.9% for FY26, based on top 12 analyst calls.